The performance of an assay to detect antibodies to a norovirus nonstructural fusion protein, designated VPR and consisting of three proteins (GI.1 virus protein genome-linked [VPg], a virus protease, and an RNA-dependent RNA polymerase), was evaluated. The assay sensitivity and specificity were 74.5% and>95%, respectively, for identifying GI.1 norovirus infection among persons who received either a monovalent GI.1 norovirus virus-like particle (VLP) vaccine or placebo by the intranasal route followed by an oral live GI.1 norovirus challenge.
CITATION STYLE
Hesse, S., Neill, F. H., Estes, M. K., Shanker, S., Prasad, B. V. V., Ferreira, J., & Atmar, R. L. (2016). Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clinical and Vaccine Immunology, 23(2), 181–183. https://doi.org/10.1128/CVI.00595-15
Mendeley helps you to discover research relevant for your work.